Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
PharmAbcine Announces Last Patient Last Visit in its Phase Ib mTNBC Combination Trial 2022-02-25 21:00
PharmAbcine Announces Patent Grant in Australia for Its Anti-VISTA Antibody 2021-10-19 20:00
PharmAbcine to Participate in BIO-Europe 2021 2021-09-20 20:00
PharmAbcine to Participate in ACCESS CHINA Biotech Forum 2021-09-13 20:00
PharmAbcine Announces Joint Patent Application with MSD for the Treatment of Cancer 2021-09-09 20:00
PharmAbcine Receives HREC Clearance for Phase II Trial of Olinvacimab and Pembrolizumab in mTNBC 2021-09-03 20:00
PharmAbcine to Participate in H.C. Wainright 23rd Annual Global Investment Conference 2021-08-23 20:00
PharmAbcine Announces Submission of PCT for an Anti-ANG2 Antibody for the Treatment of Ocular Diseases 2021-08-19 20:00
PharmAbcine to Participate in Biotechgate Digital Partnering 2021-08-17 20:00
PharmAbcine to Present at H.C Wainwright Ophthalmology Virtual Conference 2021-07-26 20:00
PharmAbcine to Present at the BIO Digital International Convention 2021 2021-06-02 20:00
PharmAbcine Announces Encouraging Non-clinical Data of PMC-403 at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting 2021-05-10 20:00
PharmAbcine to Present at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Annual Meeting 2021-04-26 20:00
PharmAbcine announces Clinical Trial Collaboration with MSD for the Phase II study in mTNBC 2021-04-19 20:00
PharmAbcine presents the non-clinical data of PMC-309 at AACR 2021 2021-04-12 20:00
PharmAbcine to Present at AACR Annual Meeting 2021 2021-03-11 21:00
PharmAbcine announces a research collaboration with LegoChem Biosciences 2021-01-11 21:00
PharmAbcine to participate in BIO @ JPM and Biotech Showcase Digital during "J.P. Morgan Week 2021" 2021-01-04 21:00
PharmAbcine presents the latest data of the ongoing Phase Ib mTNBC trial at SABCS 2020 2020-12-09 23:00
PharmAbcine to present new interim data from its ongoing mTNBC trial at SABCS 2020 2020-12-07 21:00
1 2 3